Govt likely to invite EoI for CONCOR divestment in December

DIPAM started a pre-EoI roadshow for potential bidders on October 19 to measure investors' interest in the divestment from CONCOR, the company said in an exchange filing. The roadshow was held virtually until October 21, the filing said

Yaruqhullah Khan

December 01, 2022 / 21:45 IST

The Central government plans to invite bids for Container Corporation of India (CONCOR) in December, following which potential bidders will have around 20 days to submit their bids for the state-owned logistics company, two people close to the development said.

A senior government official said the government is looking to prioritize the divestment of CONCOR and is hopes to invite financial bids in 2022-23.

He added that three or four companies had participated in the second round of the pre-expression of interest (EoI) roadshows held by the Department of Investment and Public Asset Management (DIPAM).

JSW Group, Maersk and Essar Ports have shown interest in bidding for CONCOR, a second government official said.

Moneycontrol could not confirm this separately from these companies

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show